BriaCell Therapeutics Corp. (BCTX) Ownership
BCTX ownership summary
as of October 18, 2026- Institutions
- 6.4% of shares outstanding
- Insiders
- 0.04% of shares outstanding
- Shares outstanding
- 8.7M
- Float
- 7.9M shares available to trade
- Short interest
- 8.96% 779K shares short
- Days to cover
- 5.03 short interest down 1.7% vs prior month
- Institutions 6.39%
- Insiders 0.04%
- Other investors 93.56%
BCTX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Cable Car Capital LLC | 2.49% | 217K | $737,191 | — | June 30, 2026 |
| 2 | Sabby Management LLC | 0.93% | 81K | $274,451 | +6,806 (+9.2%) | June 30, 2026 |
| 3 | Iridian Asset Management LLC | 0.75% | 65K | $221,000 | — | June 30, 2026 |
| 4 | UBS Group AG | 0.50% | 44K | $148,383 | +32,101 (+278.1%) | June 30, 2026 |
| 5 | HRT FINANCIAL LLC | 0.40% | 35K | $118,674 | +34,904 (0.0%) | June 30, 2026 |
| 6 | Jane Street Group LLC | 0.30% | 27K | $90,151 | +26,515 (0.0%) | June 30, 2026 |
| 7 | LuminArx Capital Management LP | 0.17% | 15K | $51,000 | — | June 30, 2026 |
| 8 | NATIONAL BANK OF CANADA /FI/ | 0.02% | 1,803 | $6,130 | +1,001 (+124.8%) | June 30, 2026 |
| 9 | Morgan Stanley - Brokerage Accounts | 0.01% | 1,033 | $3,512 | −1,988 (−65.8%) | June 30, 2026 |
| 10 | Federation des caisses Desjardins du Quebec | 0.01% | 450 | $1,530 | −5 (−1.1%) | June 30, 2026 |
| 11 | Royal Bank of Canada | <0.01% | 289 | $983 | +289 (0.0%) | June 30, 2026 |
| 12 | Hanson Mcclain Inc | <0.01% | 100 | $340 | — | June 30, 2026 |
| 13 | SSA SWISS ADVISORS AG | <0.01% | 37 | $126 | +37 (0.0%) | June 30, 2026 |
| 14 | Caitong International Asset Management Co., Limited. | <0.01% | 34 | $116 | +27 (+385.7%) | June 30, 2026 |
| 15 | TD Waterhouse Canada Inc | <0.01% | 19 | $65 | — | June 30, 2026 |
| 16 | Group One Trading, LLC | <0.01% | 16 | $54 | — | June 30, 2026 |
| 17 | HHM Wealth Advisors, LLC | <0.01% | 6 | $20 | — | June 30, 2026 |
| 18 | Wells Fargo & Co | 0.00% | 1 | $3 | — | June 30, 2026 |
| 19 | Tower Research Capital LLC | 0.00% | — | — | −9 (−100.0%) | March 31, 2026 |
| 20 | FLAGSHIP HARBOR ADVISORS, LLC | 0.00% | — | — | −4,000 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 102K shares and 4 cut 6,002.
BCTX top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.04% | 3,231 | $10,985 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
BCTX insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-12-28 | Jamieson Bondarenko | Buy | $687.00 | 186 | $127,782 |
| 2022-12-20 | Jamieson Bondarenko | Buy | $802.50 | 146 | $117,165 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
BCTX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns BCTX
Institutional investors own 6.4% of BriaCell Therapeutics's shares and insiders 0.04%. The largest holder is Cable Car Capital LLC with 2.49% of the shares (217K), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 4 reduced their stake in the latest filings. Short interest is 8.96% of the float, or 5.03 days of average trading volume. The share count rose 17,026.4% since 2014.
Related: BCTX analyst forecast, BCTX key metrics. See the BCTX stock overview for the latest quote and news.
BCTX ownership FAQ
Who owns the most BriaCell Therapeutics stock?
The largest shareholders of BriaCell Therapeutics are Cable Car Capital LLC (2.49%), Sabby Management LLC (0.93%), Iridian Asset Management LLC (0.75%), UBS Group AG (0.50%), HRT FINANCIAL LLC (0.40%).
What percentage of BriaCell Therapeutics is owned by institutions?
Institutions hold 6.4% of BriaCell Therapeutics's shares outstanding; insiders hold 0.04%.
Which funds own BriaCell Therapeutics?
The largest fund holders of BriaCell Therapeutics are Fidelity Nasdaq Composite Index (0.04%).
What is BriaCell Therapeutics's short interest?
779K shares of BriaCell Therapeutics were sold short, 8.96% of the float; at the average daily volume it would take 5.03 days to cover.
Are insiders buying or selling BriaCell Therapeutics?
Of the latest 2 reported insider transactions in BriaCell Therapeutics (since December 20, 2022), 2 were purchases and 0 were sales.
How many shares of BriaCell Therapeutics are outstanding?
BriaCell Therapeutics has 8.7M shares outstanding, of which 7.9M are in the public float.